More speakers will be announced over the coming weeks.
Prof Nicholas Buckley
The University of Sydney
Prof Nicholas Buckley
Nick Buckley (MD FRACP) is Professor of Clinical Pharmacology at the University of Sydney, a consultant clinical toxicologist at the NSW Poisons Information Centre and RPA Hospital, Chair of the Editorial Advisory Board of the Australian Medicines Handbook, Deputy Editor of Clinical Toxicology, a past President of The Asia Pacific Association of Medical Toxicology, and Research Director of the South Asian Clinical Toxicology Research Collaboration (SACTRC- http://www.sactrc.org). SACTRC does clinical and public health research on pesticides, plant & pharmaceutical poisoning, snakebite, translation into practice, neurotoxicity and kidney biomarkers. In Australia, his research has largely been clinical, epidemiological and pharmaco-epidemiological studies on analgesic and psychotropic drug poisoning & misuse. His research has attracted continuous project and program funding since 2002 which has resulted in an extensive publication record including 480+ peer reviewed journal articles and 25 book chapters.
Dr Andrea Kwa, a distinguished pharmacist clinician -scientist, has had a remarkable journey fueled by her curiosity. She excels in translational science, where she conducts evidence-based research and translate discoveries into practical applications, ensuring top-tier patient care. She specialised in critical care medicine, infectious diseases, and antimicrobial resistance research, specifically in in-vitro wet bench translational (phage therapy, antibiotics combination testing), population PKPD studies, molecular diagnostics in anti-fungal and antibacterial resistance, epidemiology/outcomes studies and health services research (specifically AI/ML for AMR management) to guide antimicrobial stewardship. To date, she has authored more than 120 publications.
The First Affiliated Hospital, Sun Yat-Sen University
Dr Xiaoman Liu
Xiaoman Liu is a clinical pharmacist at the First Affiliated Hospital, Sun Yat-sen University (FAH-SYSU), China. She received her Ph.D. from the University of Sydney, Australia. Dr Liu’s research focuses on pharmacogenetics- and pharmacokinetics-based personalised medicine, with a particular emphasis on immunosuppressive therapy. She is a co-author of the International Pharmaceutical Federation (FIP) consensus on the management of immunosuppressants and has contributed to multiple journal articles and book chapters. The FAH-SYSU pharmacy research team is dedicated to investigating the effects of genetic polymorphisms and pharmacokinetic variability on drug levels, efficacy, and side effects, with the aim of improving the safety and effectiveness of medications for pediatric patients and individuals with immunocompromised conditions.
Kevin Plaxco, a Distinguished Professor at the University of California, Santa Barbara, holds appointments in the Departments of Chemistry and Biochemistry and of BioEngineering. Prior to joining UCSB in 1998 Dr Plaxco received his Ph.D. from Caltech and performed postdoctoral studies at Oxford and the University of Washington. Dr Plaxco’s research focus is on the physics of biomolecular folding and its engineering applications. A major aim of the group’s applied research is to harness the speed and specificity of folding in the development of sensors, adaptable surfaces, and smart materials. Dr Plaxco has co-authored more than 250 papers and two dozen patents on protein folding, protein dynamics, and folding-based sensors and materials. He serves on the scientific boards of a half dozen biotechnology firms, several of which are commercializing technologies developed by his group, and has also written a popular science book on Astrobiology.
